Dopamine Index
Gambling
In plain English
Gambling addiction does involve dopamine, but the clearest human proof of that does not come from studying gamblers directly. It comes from Parkinson’s disease, where drugs that boost dopamine cause new-onset gambling problems in roughly half of long-term users, and those problems fade once the drug is reduced. Brain scans of people who already have gambling disorder are smaller and messier, and have not consistently found the same clean signal.
The evidence
- Evidence
- CC — Limited
- Human evidence
- Yes · Parkinson’s dopamine-agonist trials give strong evidence; direct gambling-disorder imaging is small.
- Studies reviewed
- 4
- Verdict
- Explainer — no single claim judged
- How sure are we?
- Uncertain
- Last reviewed
- Grade status
- Provisional — awaiting editorial validation
Short answer
Gambling disorder is officially recognised as a behavioural addiction, and the strongest evidence that dopamine is genuinely involved does not come from studying gamblers directly — it comes from Parkinson’s disease. Dopamine-agonist drugs used to treat Parkinson’s cause new-onset gambling and other impulse-control problems in roughly half of long-term users, in a clear dose-response pattern that resolves when the drug is withdrawn. Direct brain-imaging studies in people with gambling disorder are smaller and more mixed.
- Evidence
- CEvidence grade C · Limited or observational human evidence
- Why this grade
- Direct human PET/SPECT studies in gambling disorder are small (13-20 people per study) and give mixed results for dopamine specifically 1 2. The strongest evidence dopamine can causally drive gambling-like behaviour comes from a different population — people with Parkinson’s disease on dopamine agonists 3 4 — which supports the mechanism generally but is not a direct study of gambling disorder itself, keeping the grade at C for gambling disorder specifically.
- Last reviewed
- 24 September 2026
The quick explanation
Gambling disorder is now classified as a behavioural addiction, and researchers have looked for a dopamine signature the way they look for one with drugs. Small brain-imaging studies directly in people with gambling disorder give a mixed picture: one study found no link between gambling-cue brain responses and dopamine synthesis specifically, pointing instead to the opioid system, while another found dopamine-transporter levels tracked impulsivity across everyone studied but did not clearly separate people with gambling disorder from controls. The much stronger evidence for a real dopamine link comes from Parkinson’s disease, where drugs that directly boost dopamine signalling reliably cause new gambling problems in some patients, and those problems fade when the drug is reduced.
What it is
Gambling disorder is a recognised behavioural addiction involving persistent, problematic gambling despite harmful consequences, and is the most-studied non-substance addiction in dopamine research.
Does dopamine play a role?
Probably, but the direct evidence in people with gambling disorder itself is smaller and more mixed than many assume; the clearest, strongest evidence that dopamine signalling can cause gambling-like behaviour comes from a different, better-controlled natural experiment in Parkinson’s disease.
Human evidence
Gambling disorder is the most studied non-substance behavioural addiction, and researchers have tried to find the same kind of dopamine signature in gamblers that decades of PET research has found in people who use drugs. The direct results, so far, are smaller and messier than that comparison implies.
One recent multimodal imaging study scanned 13 people with gambling disorder and 16 healthy controls while they watched gambling-related, erotic and neutral videos, combined with PET imaging of three different neurotransmitter systems: dopamine ([18F]FDOPA), opioid ([11C]carfentanil) and serotonin ([11C]MADAM). People with gambling disorder showed significantly greater brain activity in the dorsal striatum specifically to gambling cues, not to natural reward cues like erotic images. But that gambling-specific brain activity correlated with opioid receptor binding, not with dopamine synthesis capacity.1
A separate SPECT imaging study of 20 older adults with gambling disorder and 40 age- and sex-matched controls looked specifically at dopamine transporter binding in the striatum. Binding correlated positively with impulsivity across the whole sample — people with and without gambling disorder combined — but did not differ significantly between the gambling-disorder group and controls. A clearer group difference showed up in serotonin transporter binding in the prefrontal cortex instead.2
Put together, these two studies do not rule dopamine out of gambling disorder, but they do not offer the clean, direct confirmation that a simple ‘gambling hijacks your dopamine system’ headline implies either.12
The much stronger, and genuinely compelling, human evidence for a causal dopamine-gambling link comes from an unrelated context: Parkinson’s disease treatment. A five-year longitudinal study followed 411 people with Parkinson’s disease and found that those who took dopamine agonist drugs had a cumulative incidence of impulse control disorders, including problem gambling, of about 46% over five years, compared with about 12% in patients who never took a dopamine agonist — a clear dose-response relationship, with both higher daily doses and longer treatment duration increasing risk.3
Crucially, these Parkinson’s impulse control disorders progressively resolved after the dopamine agonist was withdrawn, which is about as close to a natural experiment as this field offers: increase dopamine signalling pharmacologically, gambling-type behaviour appears in some people; reduce it again, the behaviour recedes. That is genuinely strong causal evidence for a dopamine role in this kind of compulsive behaviour, even though it comes from a Parkinson’s population rather than typical gambling disorder.3
An international expert consensus statement on managing these Parkinson’s impulse control disorders recommends gradual dopamine agonist reduction as the first-line response, alongside monitoring and support, reinforcing that clinicians treat the dopaminergic medication itself as the primary lever.4
Animal evidence
The sources reviewed for this page are all human clinical and imaging studies; no animal gambling-specific dopamine evidence is presented here, since the strongest and most relevant evidence for gambling specifically already comes directly from people, through the Parkinson’s agonist studies above.
Mechanism
Dopamine agonist drugs used in Parkinson’s disease directly stimulate dopamine receptors, essentially amplifying dopamine signalling pharmacologically. The clear dose-response relationship with impulse control disorders, and the resolution of those disorders on withdrawal, points to dopamine receptor stimulation itself, rather than Parkinson’s disease as an illness, as the operative mechanism.3
Why gambling-disorder imaging looks different
It is not resolved why direct brain imaging in people with gambling disorder has not, so far, shown the same clear dopamine signature that the Parkinson’s agonist evidence would predict. Possibilities raised in the source studies include small sample sizes, the specific brain regions and radiotracers used, and a genuine possibility that other systems such as opioids and serotonin play a larger role in gambling disorder that develops without dopaminergic medication.12
One reading that fits all four sources together is that dopamine signalling is capable of driving gambling-like behaviour — the Parkinson’s evidence makes that hard to dispute — but that everyday gambling disorder, which usually develops without any dopaminergic drug involved, may involve a more distributed set of systems (dopamine, opioid, serotonin) working together, none of which shows up as cleanly on its own in a small imaging study as an entire medication class does in a five-year cohort.31
For anyone reading the two labels side by side, it is worth remembering they are answering different questions. The Parkinson’s studies ask ‘can boosting dopamine signalling cause gambling-type behaviour’, and answer yes, clearly. The gambling-disorder imaging studies ask ‘does gambling disorder, once established, show an abnormal dopamine signature’, and the honest answer so far is: not as clearly or consistently as expected.32
Evidence strength
Direct human PET/SPECT studies in gambling disorder are small (13-20 people per study) and give mixed results for dopamine specifically 1 2. The strongest evidence dopamine can causally drive gambling-like behaviour comes from a different population — people with Parkinson’s disease on dopamine agonists 3 4 — which supports the mechanism generally but is not a direct study of gambling disorder itself, keeping the grade at C for gambling disorder specifically.
Common claims
| What people say | What the evidence says |
|---|---|
| Gambling disorder is caused by an overactive dopamine system, just like drug addiction | unproven as a direct claim about gambling disorder — imaging studies in gamblers themselves have not clearly confirmed this 1 2 |
| Dopamine drugs can cause someone to develop a gambling problem who never had one before | true, and this is some of the strongest causal evidence anywhere in this index for a dopamine-behaviour link 3 |
| Stopping the dopamine drug fixes the problem | mostly true in the Parkinson’s population studied, where impulse control disorders progressively resolved after dopamine agonist withdrawal 3 |
What the evidence supports
- Dopamine agonist medication in Parkinson’s disease causes a large, dose-dependent increase in gambling and related impulse-control problems, and stopping the drug reverses this 3.
- Striatal dopamine transporter binding correlated with impulsivity, a core risk factor for gambling disorder, across a mixed sample of people with and without the disorder 2.
What the evidence does not support
- Dopamine transporter binding did not differ between people with gambling disorder and matched controls in a direct comparison, even though it correlated with impulsivity generally 2.
- Gambling-cue-induced brain activity in a small imaging study of gambling disorder correlated with opioid receptor binding, not with dopamine synthesis capacity, suggesting the opioid system may matter as much or more for cue reactivity specifically 1.
Potential risks
Gambling disorder can cause serious financial, relationship and mental health harm; if gambling is causing problems for you or someone you know, GamCare (0808 8020 133) is a free, confidential, UK-wide support line.
What we know
- In a small PET/fMRI study of 13 people with gambling disorder and 16 healthy controls, gambling-related cues produced greater brain activity in the dorsal striatum in the gambling-disorder group, but this activity correlated with opioid receptor binding, not with dopamine synthesis capacity 1.
- In a SPECT study of 20 older adults with gambling disorder and 40 matched controls, striatal dopamine transporter binding correlated positively with impulsivity across the whole sample, but did not differ between the gambling-disorder group and controls; serotonin transporter binding in the prefrontal cortex showed a clearer group difference 2.
- In people with Parkinson’s disease, dopamine agonist drugs were associated with a 5-year cumulative incidence of impulse control disorders (including gambling) of about 46%, versus about 12% in patients who never took a dopamine agonist, with a clear dose-response relationship 3.
- These Parkinson’s impulse control disorders progressively resolved after the dopamine agonist was withdrawn, supporting a causal, reversible role for dopamine signalling rather than a coincidental association 3.
What we don’t know
- Why direct PET/SPECT studies in people with gambling disorder itself have not consistently found the same clear dopamine signal that the Parkinson’s agonist studies imply should exist.
- How well the Parkinson’s dopamine-agonist model of drug-induced gambling problems generalises to gambling disorder that develops without any dopaminergic medication involved.
- Whether the opioid-system finding in the cue-reactivity study means opioid signalling, not dopamine, is the more important driver of gambling urges specifically, as opposed to dopamine’s more general role in motivation.
How sure are we?
- Very confident
- Reasonably confident
- Uncertain
- Very uncertain
Uncertain. Direct imaging in gambling disorder is small and mixed 12, even though the separate Parkinson’s evidence for a causal dopamine role is strong 3.
Confidence describes how settled the answer on this page is, not how important the topic is. It can change as new research is published.
Where scientists disagree
The Parkinson’s agonist studies show dopamine can clearly cause gambling-like behaviour 34, but direct brain imaging in people with gambling disorder itself has not found the same clear dopamine signature, instead implicating opioid and serotonin systems 12.
Why studies may disagree
Possible explanations include small sample sizes, the specific brain regions and radiotracers used, and a genuine possibility that gambling disorder without dopaminergic medication involves a more distributed set of systems 12.
What would change the answer?
The evidence that is currently missing:
- Larger PET/SPECT studies directly in people with gambling disorder
- Studies testing whether opioid or serotonin signalling, not dopamine, drives cue reactivity
- Direct comparison of medication-induced and naturally occurring gambling disorder
Common misconception
Brain scans of people with gambling disorder clearly show an overactive dopamine system, the same as with drug addiction.
Direct imaging studies in gambling disorder are small and have not consistently found a clear dopamine-specific signature; one recent study found gambling-cue brain activity tracked opioid receptor binding, not dopamine synthesis 1, while dopamine transporter levels did not differ between people with gambling disorder and controls in another 2.
Key studies
- Multimodal imaging study, 13 people with gambling disorder vs 16 controls: gambling-cue-induced dorsal striatal activity correlated with opioid receptor binding, not with dopamine (FDOPA) or serotonin binding.1
- SPECT study, 20 older adults with gambling disorder vs 40 controls: striatal dopamine transporter binding correlated with impulsivity across the sample but showed no group difference; prefrontal serotonin transporter binding did differ by group.2
- 5-year longitudinal cohort, 411 people with Parkinson’s disease: dopamine agonist use was associated with a 46% cumulative incidence of impulse control disorders (including gambling) vs 12% in never-users, with a dose-response relationship.3
- International Delphi consensus statement on managing impulse control and related disorders in Parkinson’s disease, including gambling, endorsing gradual dopamine agonist reduction as first-line management.4
Medical and safety guidance
This page is not medical advice about gambling. GamCare (0808 8020 133) offers free, confidential support for anyone affected by gambling, including family members, and a GP can help with related health concerns.
The bottom line
The strongest human proof that dopamine can drive gambling-like behaviour comes from Parkinson’s medication, not from studying people with gambling disorder directly. Scans of gambling disorder itself are small and have not clearly confirmed a dopamine signature.
Related questions
The Brief
Understand your brain a little better each week.
Join The Brief from dopamine.co.uk. Free. No spam, no supplements, no selling your address. Unsubscribe in one click.
References
- 1. Bellmunt-Gil A, et al. Striatal cue-reactivity and neurotransmitter function in gambling disorder. Journal of behavioral addictions. 2025. PMID 40434828. doi:10.1556/2006.2025.00041
- 2. Kaasinen V, et al. Serotonergic and dopaminergic control of impulsivity in gambling disorder. Addiction biology. 2023. PMID 36692875. doi:10.1111/adb.13264
- 3. Corvol JC, et al. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology. 2018. PMID 29925549. doi:10.1212/WNL.0000000000005816
- 4. Debove I, et al. Management of Impulse Control and Related Disorders in Parkinson’s Disease: An Expert Consensus. Movement disorders : official journal of the Movement Disorder Society. 2024. PMID 38234035. doi:10.1002/mds.29700